Metformin keeps CD8(+) T cells active and moving in NASH-HCC immunotherapy. Lujambio A, Sarobe P. J Hepatol 2022;77:593-595.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lujambio A, Sarobe P. Metformin keeps CD8(+) T cells active and moving in NASH-HCC immunotherapy. J Hepatol 2022;77:593-595.
PMID: 35714813